The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Baricitinib
Australian Public Assessment Report
Device/Product Name
Olumiant
Active ingredients
Baricitinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2019-05319-1-1
Submission Type
Extension of indications
Decision
Approved